Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 11Gliosarcoma 8Prostatic Neoplasms 7Glioblastoma 7Squamous Cell Carcinoma of Head and Neck 5Lung Neoplasms 5Breast Neoplasms 4Brain Neoplasms 4Sarcoma 3Astrocytoma 3Wilms Tumor 2Malignant mesenchymal tumor 2Liposarcoma 2Leiomyosarcoma 2Histiocytoma, Malignant Fibrous 2Hemangiosarcoma 2Head and Neck Neoplasms 2Fibrosarcoma 2Central Nervous System Neoplasms 2Adenocarcinoma, Bronchiolo-Alveolar 2Adenocarcinoma of Lung 2Vulvar Neoplasms 1Vomiting 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Rhabdoid Tumor 1

Interventions

Dexamethasone 21Palonosetron 16Aprepitant 14Ondansetron 12Calcium Dobesilate 11Granisetron 7fosaprepitant 6dexamethasone acetate 5Doxorubicin 4netupitant, palosentron drug combination 3dexamethasone 21-phosphate 3Olanzapine 3Diphenhydramine 3Cyclophosphamide 3Cisplatin 3netupitant 2Vincristine 2Therapeutics 2Surveys and Questionnaires 2Sugars 2Radiotherapy 2Metoclopramide 2Mesna 2Lorazepam 2Ifosfamide 2Fluorouracil 2Dronabinol 2rolapitant 1phenazine 1ginger extract 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Vomiting × Radiotherapy, Conformal × Clear all
NCT00895245 2017-05-18

Fosaprepitant Dimeglumine, Palonosetron Hydrochloride, and Dexamethasone in Preventing Nausea and Vomiting Caused by Cisplatin in Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy

University of Washington

Phase 2 Terminated
6 enrolled 5 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡